VIEMED HEALTHCARE, INC. Current Income Tax Expense (Benefit)
VIEMED HEALTHCARE, INC. (VMD) reported Current Income Tax Expense (Benefit) of $3.28 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-04
- VIEMED HEALTHCARE, INC. current income tax expense (benefit) for fiscal 2025 was $3.28M, a 61.84% decline from fiscal 2024.
- VIEMED HEALTHCARE, INC. current income tax expense (benefit) for fiscal 2024 was $8.60M, a 53.95% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. current income tax expense (benefit) for fiscal 2023 was $5.59M, a 446.67% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. current income tax expense (benefit) for fiscal 2022 was $1.02M.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.28M 10-K · filed 2026-03-04 |
| 2024-12-31 | $8.60M 10-K · filed 2026-03-04 |
| 2023-12-31 | $5.59M 10-K · filed 2026-03-04 |
| 2022-12-31 | $1.02M 10-K · filed 2025-03-10 |
| 2021-12-31 | -$507.00K 10-K · filed 2023-03-02 |
| 2020-12-31 | $3.57M 10-K · filed 2022-03-07 |
| 2019-12-31 | $271.00K 10-K · filed 2021-03-03 |
| 2018-12-31 | $162.00K 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |